BioMarin Pharmaceutical Inc.
Symbol: BMRN
NASDAQ
82.44
USDDzisiejsza cena rynkowa
75.7836
Wskaźnik P/E
2.6945
Wskaźnik PEG
15.65B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
BioMarin Pharmaceutical Inc. (BMRN) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 4417.19 | 1073.8 | 1291.5 | 1013.9 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 1435.28 | 318.7 | 567 | 426.6 | ||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 2453.59 | 633.7 | 461.3 | 373.4 | ||||||||||||||||||||||||||
balance-sheet.row.inventory | 4252.87 | 1107.2 | 894.1 | 776.7 | ||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 722.88 | 141.4 | 104.5 | 110.4 | ||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 11846.52 | 2956.1 | 2751.5 | 2274.4 | ||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 4260.99 | 1112.2 | 1073.4 | 1035.5 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill | 784.8 | 196.2 | 196.2 | 196.2 | ||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1187.17 | 294.7 | 338.6 | 388.7 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1971.97 | 490.9 | 534.8 | 584.9 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2165.47 | 615.4 | 333.8 | 507.8 | ||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 6125.1 | 1545.8 | 1505.4 | 1449.1 | ||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 665.56 | 121.2 | 176.2 | 151.8 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 15189.09 | 3885.5 | 3623.6 | 3728.9 | ||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-assets | 27035.61 | 6841.6 | 6375.1 | 6003.3 | ||||||||||||||||||||||||||
balance-sheet.row.account-payables | 1856 | 315.5 | 231.2 | 193 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 1489.93 | 502.7 | 10.4 | 10.5 | ||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 38.28 | 2.7 | 16.2 | 3.1 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 2864.28 | 593.1 | 1083 | 1079.1 | ||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 2543.75 | 354.2 | 346.6 | 329.4 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 3305.14 | 713 | 1183 | 1192.8 | ||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 1059.32 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 64.32 | 38.1 | 10.4 | 10.5 | ||||||||||||||||||||||||||
balance-sheet.row.total-liab | 7330.52 | 1890.1 | 1771.9 | 1732.6 | ||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0.76 | 0.2 | 0.2 | 0.2 | ||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | -2478.68 | -621.6 | -789.2 | -925.7 | ||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -53.89 | -38.6 | -3.9 | 14.4 | ||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 22236.91 | 5611.6 | 5396 | 5181.8 | ||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 19705.09 | 4951.5 | 4603.2 | 4270.7 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 27035.61 | 6841.6 | 6375.1 | 6003.3 | ||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-equity | 19705.09 | 4951.5 | 4603.2 | 4270.7 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 27035.61 | - | - | - | ||||||||||||||||||||||||||
Total Investments | 2980.19 | 934.1 | 900.8 | 934.4 | ||||||||||||||||||||||||||
balance-sheet.row.total-debt | 4345.91 | 1133.9 | 1083 | 1079.1 | ||||||||||||||||||||||||||
balance-sheet.row.net-debt | 1363.99 | 378.7 | 358.5 | 491.8 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 205.46 | 167.6 | 141.6 | -64.1 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 105.31 | 104.4 | 102 | 108 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -38.34 | -45 | -52.1 | -15.6 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 211.65 | 207099 | 196.3 | 197.3 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -225.28 | -336.5 | -96.4 | 66 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | -55.02 | -190.4 | -82 | 65.6 | ||||||||||||||||||||||||||
cash-flows.row.inventory | -159.78 | -157.1 | -68.3 | -35.1 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 41.53 | 68.9 | 59 | 15689 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | -52.01 | -57.9 | -5.1 | -15653.5 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 616.91 | -206830.3 | -115.5 | 12.9 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 280.16 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -116.95 | -107.6 | -131.5 | -119.2 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | -27.05 | 10920 | 0 | -23.6 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -769.8 | -868.5 | -611.8 | -937.1 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 781.28 | 864.9 | 620 | 691 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 37.05 | -10920 | 103.3 | 22.7 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -95.47 | -111.2 | -20 | -366.3 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | -1.31 | -2.3 | -2.6 | -3 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 55.38 | 69.4 | 69.3 | 49.2 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -74.84 | 0 | -54.3 | -45.8 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -15.1 | -3.4 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | -32.89 | -85.8 | -16 | 3 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -20.78 | -18.7 | -18.6 | 0 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1978.77 | 1308 | 0 | -0.1 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 166.92 | 30.6 | 137.3 | -61.9 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2981.92 | 755.1 | 724.5 | 587.3 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2815 | 724.5 | 587.3 | 649.2 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 280.16 | 159.3 | 175.9 | 304.5 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -116.95 | -107.6 | -131.5 | -119.2 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 163.21 | 51.6 | 44.4 | 185.3 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 2475.6 | 2419.2 | 2096 | 1846.3 | ||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 559.06 | 577.1 | 483.7 | 470.5 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 1916.54 | 1842.2 | 1612.4 | 1375.8 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
income-statement-row.row.research-development | 779.91 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 343.64 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 370.7 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 196.88 | -10.5 | 67.2 | 69.9 | ||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1740.86 | 1684.6 | 1570.8 | 1458.1 | ||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 2299.92 | 2261.6 | 2054.5 | 1928.6 | ||||||||||||||||||||||||||
income-statement-row.row.interest-income | 65.76 | 58.3 | 18 | 10.5 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 17.18 | 17.3 | 16 | 15.3 | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 370.7 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 61.67 | 31 | 92 | -15.3 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 196.88 | -10.5 | 67.2 | 69.9 | ||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 61.67 | 31 | 92 | -15.3 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 17.18 | 17.3 | 16 | 15.3 | ||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 105.31 | 104.4 | 102 | 108 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 281 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.operating-income | 175.68 | 157.6 | 57.5 | -60 | ||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 237.35 | 188.6 | 149.6 | -75.3 | ||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 31.9 | 20.9 | 8 | -11.3 | ||||||||||||||||||||||||||
income-statement-row.row.net-income | 205.46 | 167.6 | 141.6 | -64.1 |
Często zadawane pytania
Ile wynosi BioMarin Pharmaceutical Inc. (BMRN) aktywów ogółem?
BioMarin Pharmaceutical Inc. (BMRN) całkowite aktywa to 6841603000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 1295040000.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.774.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.864.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.083.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.071.
Co to jest BioMarin Pharmaceutical Inc. (BMRN) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 167645000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 1133875000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 1684564000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 746996000.000.